Acetylsalicylic acid Completed Phase 4 Trials for Noncardioembolic Cerebral Infarction Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01995370Cilostazol Stroke Prevention Study for Antiplatelet Combination